Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention Strategies

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Current hepatocellular carcinoma (HCC) treatments are insufficient, necessitating novel therapeutic strategies.
• RNA epigenetic modifications, including N6-methyladenosine (m6A) and 5-methylcytosine (m5C), are increasingly recognized for their roles in cancer.
• The precise mechanisms by which these RNA modifications influence HCC remain incompletely understood.

Purpose of the Study:

• To review the occurrence and physiopathological roles of multiple RNA modifications in hepatocellular carcinoma (HCC).
• To elucidate the impact mechanisms of these posttranscriptional modifications on HCC progression.
• To analyze the therapeutic potential of RNA modifications and their regulators as targets for HCC treatment.

Main Methods:

• Literature review focusing on recent research in RNA epigenetics and HCC.
• Analysis of diverse RNA modifications and their involvement in HCC pathogenesis.
• Evaluation of potential therapeutic strategies targeting RNA modification pathways.

Main Results:

• Multiple RNA modifications are prevalent and play significant roles in HCC development and progression.
• These modifications impact various RNAs crucial to the HCC process.
• The study highlights specific mechanisms through which RNA modifications influence HCC.

Conclusions:

• RNA epigenetic modifications and their regulators represent promising therapeutic targets for HCC.
• Further research into these modifications can lead to novel, clinically applicable treatment strategies for HCC.
• This review provides a foundation for developing targeted interventions in HCC therapy.